What is a stock summary page? Click here for an overview.
Business Description
Syros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US87184Q2066
Description
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.97 | |||||
| Equity-to-Asset | -0.13 | |||||
| Debt-to-Equity | -5.42 | |||||
| Debt-to-EBITDA | -0.66 | |||||
| Altman Z-Score | -15.54 | |||||
| Beneish M-Score | -7.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -52.5 | |||||
| 3-Year EBITDA Growth Rate | 31.4 | |||||
| 3-Year EPS without NRI Growth Rate | 37.6 | |||||
| 3-Year FCF Growth Rate | 33.5 | |||||
| 3-Year Book Growth Rate | -66.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 47.47 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.97 | |||||
| 9-Day RSI | 28.59 | |||||
| 14-Day RSI | 31.19 | |||||
| 3-1 Month Momentum % | -36.69 | |||||
| 6-1 Month Momentum % | -93.58 | |||||
| 12-1 Month Momentum % | -97.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.25 | |||||
| Quick Ratio | 2.25 | |||||
| Cash Ratio | 2.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -67.6 | |||||
| Shareholder Yield % | 229.75 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -28892.23 | |||||
| Net Margin % | -25340.67 | |||||
| FCF Margin % | -25920.73 | |||||
| ROE % | -967.58 | |||||
| ROA % | -76.13 | |||||
| ROIC % | -324.04 | |||||
| 3-Year ROIIC % | 291.44 | |||||
| ROC (Joel Greenblatt) % | -490.78 | |||||
| ROCE % | -94.93 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.94 | |||||
| EV-to-EBIT | -0.03 | |||||
| EV-to-EBITDA | -0.03 | |||||
| EV-to-Revenue | 7.06 | |||||
| EV-to-Forward-Revenue | 26.86 | |||||
| EV-to-FCF | -0.03 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Earnings Yield (Greenblatt) % | -3372.49 | |||||
| FCF Yield % | -12943.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syros Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.386 | ||
| EPS (TTM) ($) | -3.07 | ||
| Beta | 0.5 | ||
| 3-Year Sharpe Ratio | -0.26 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 141.64 | ||
| 14-Day RSI | 31.19 | ||
| 14-Day ATR ($) | 0.028051 | ||
| 20-Day SMA ($) | 0.07474 | ||
| 12-1 Month Momentum % | -97.34 | ||
| 52-Week Range ($) | 0.023 - 6.78 | ||
| Shares Outstanding (Mil) | 26.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syros Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syros Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syros Pharmaceuticals Inc Frequently Asked Questions
What is Syros Pharmaceuticals Inc(LTS:0LC7)'s stock price today?
The current price of LTS:0LC7 is $0.03. The 52 week high of LTS:0LC7 is $6.78 and 52 week low is $0.02.
When is next earnings date of Syros Pharmaceuticals Inc(LTS:0LC7)?
The next earnings date of Syros Pharmaceuticals Inc(LTS:0LC7) is 2025-04-03 Est..
Does Syros Pharmaceuticals Inc(LTS:0LC7) pay dividends? If so, how much?
Syros Pharmaceuticals Inc(LTS:0LC7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers